Publications by authors named "Tanya Basu"

Article Synopsis
  • - Ruxolitinib is a medication that inhibits certain proteins (JAK1 and JAK2) and is used to treat chronic graft-versus-host disease (cGvHD).
  • - While it helps manage cGvHD, ruxolitinib can lead to serious skin cancers, such as Merkel cell carcinoma.
  • - This case study emphasizes the occurrence of skin tumors in patients treated with ruxolitinib and the difficulties in treating these tumors when cGvHD is resistant to other therapies.
View Article and Find Full Text PDF

Background: Individuals with a prior diagnosis of chronic lymphocytic leukaemia (CLL) have a higher risk of developing melanoma and exhibit poorer outcomes than patients without CLL. However, there are limited data reporting the clinicopathological features of melanoma diagnosed in patients with CLL.

Aims: To review clinicopathological characteristics of patients with coexisting diagnoses of melanoma and CLL.

View Article and Find Full Text PDF

In 2020, Beck et al described a novel adult autoinflammatory syndrome entitled VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a newly-discovered disorder that connected previously unrelated inflammatory syndromes and a prototype for a new class of hematoinflammatory diseases. Eighty-nine percent of published cases have documented skin involvement, but despite the high incidence and diagnostic accessibility of skin manifestations, there has been little focus on the dermatological features of VEXAS syndrome thus far. A PubMed search of all published case reports of VEXAS syndrome to date was performed, with inclusion of all cases confirmed by genetic sequencing, and this review summarizes the reported dermatological signs.

View Article and Find Full Text PDF
Article Synopsis
  • * Patients showed ACV resistance after having chronic graft versus host disease (cGVHD), and all developed severe oral mucositis while on ACV prophylaxis, experiencing complications despite switching to foscarnet for treatment.
  • * The prolonged immunosuppression and extended aciclovir use in these patients highlight the need for vigilant monitoring and alternative treatments for HSV in HSCT recipients.
View Article and Find Full Text PDF
Article Synopsis
  • * The study presents four cases (two CMML and two MDS) where severe itching occurred, with some symptoms showing up months before the cancer diagnosis.
  • * Chemotherapy and immunosuppressive treatments have mixed results on alleviating the itch, indicating that recognizing this symptom could help in the earlier diagnosis of these blood disorders.
View Article and Find Full Text PDF

Aims: Acute graft-versus-host disease (aGVHD) is a leading cause of morbidity and mortality following allogeneic haematopoietic stem cell transplantation (HSCT). The aim of this study was to evaluate the clinical utility of a composite biomarker panel to help identify individuals at risk of developing aGVHD, and to help predict and differentiate between severity of aGVHD following T-cell-depleted allogeneic HSCT.

Methods: We retrospectively analysed our cohort of biopsy confirmed patients with aGVHD, who underwent T-cell-depleted HSCT and matched them with negative controls without any evidence of aGVHD.

View Article and Find Full Text PDF

A 51-year-old man gave a 2-year history of worsening mobility, cognitive decline and headaches. He had a history of thromboembolic stroke, recurrent transient ischaemic attacks and a spontaneous intraventricular haemorrhage. On examination, he had livedo reticularis and perniosis and a systolic murmur.

View Article and Find Full Text PDF

Sweet syndrome (SS) is an acute febrile neutrophilic dermatosis. It has been associated with malignant disease, especially acute myeloid leukaemia (AML), infections, autoimmune disorders and drugs, particularly granulocyte colony-stimulating factor (GCSF). No cause is found in the rest, which are labelled idiopathic.

View Article and Find Full Text PDF

A unique and cost effective hydrothermal procedure has been carried out for the synthesis of hexahedron shaped α MnMoO4 and its hybrid composite with graphene using three different weight percentages of graphene. Characterization techniques, such as XRD, Raman and FTIR analysis, established the phase and formation of the composite. The electrochemical characterization of the pseudocapacitive MnMoO4 and the MnMoO4/graphene composites in 1 M Na2SO4 displayed highest specific capacitances of 234 F g(-1) and 364 F g(-1), respectively at a current density of 2 A g(-1).

View Article and Find Full Text PDF